Back to Journals » Biologics: Targets and Therapy » Volume 13

Original Research

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

       
Total article views   HTML views PDF downloads Totals
11,044 Dovepress* 10,140+ 1,879 12,019
PubMed Central* 904 366 1,270
Totals 11,044 2,245 13,289
*Since 3 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar